Moleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, Including Coronavirus Mar 17, 2020
Moleculin Announces Positive Independent Report of No Cardiotoxicity in Annamycin Phase 1 To Date Feb 20, 2020
Moleculin Presents Clinical Trial Data Demonstrating a Median Reduction of 56% in Skin Cancer Lesions Feb 18, 2020
